본문 바로가기
KERD
논문KCI 등재

The importance of histomorphological features and ERG expression in the diagnosis of malignancy in cases with atypical small acinar proliferation

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류병리학

초록

Background: Atypical small acinar proliferation (ASAP) cases typically require rebiopsy, which are invasive and associated with increased risk of complications. Our aim in this study was to determine the importance of laboratory and histological findings and E-26 transformation-specific-related gene (ERG) expression in the diagnosis of malignancy. Methods: Between March 2016 and March 2022, 84 patients who were diagnosed with ASAP on biopsy or rebiopsy were included in the study. Clinical-laboratory features of age, serum prostate-specific antigen level, and histopathological features were compared and included multifocality, number of suspicious acini, nuclear enlargement, nucleolar prominence, hyperchromasia, cytoplasmic amphophilia, luminal amorphous acellular secretion, crystalloid presence, infiltrative appearance, inflammation, atrophy, α-methyl acyl-CoA racemase, p63, and/or high molecular weight cytokeratin were analyzed. In addition, ERG expression was evaluated immunohistochemically. Results: Statistically significant correlation was found between nucleolar prominence, nuclear hyperchromasia, crystalloid presence, infiltrative pattern, and prostate cancer (p < .001). In 19 of 84 cases (22.6%) ERG was positive in the nucleus. Prostate cancer was diagnosed at rebiopsy in 15 of the 19 ERG-positive cases (78.9%). A statistically significant correlation was found between ERG positivity and prostate cancer (p = .002). Conclusions: Our findings suggest that evaluation of these markers during initial transrectal ultrasound biopsies may decrease and prevent unnecessary prostate rebiopsy.

Abstract

Background: Atypical small acinar proliferation (ASAP) cases typically require rebiopsy, which are invasive and associated with increased risk of complications. Our aim in this study was to determine the importance of laboratory and histological findings and E-26 transformation-specific-related gene (ERG) expression in the diagnosis of malignancy. Methods: Between March 2016 and March 2022, 84 patients who were diagnosed with ASAP on biopsy or rebiopsy were included in the study. Clinical-laboratory features of age, serum prostate-specific antigen level, and histopathological features were compared and included multifocality, number of suspicious acini, nuclear enlargement, nucleolar prominence, hyperchromasia, cytoplasmic amphophilia, luminal amorphous acellular secretion, crystalloid presence, infiltrative appearance, inflammation, atrophy, α-methyl acyl-CoA racemase, p63, and/or high molecular weight cytokeratin were analyzed. In addition, ERG expression was evaluated immunohistochemically. Results: Statistically significant correlation was found between nucleolar prominence, nuclear hyperchromasia, crystalloid presence, infiltrative pattern, and prostate cancer (p < .001). In 19 of 84 cases (22.6%) ERG was positive in the nucleus. Prostate cancer was diagnosed at rebiopsy in 15 of the 19 ERG-positive cases (78.9%). A statistically significant correlation was found between ERG positivity and prostate cancer (p = .002). Conclusions: Our findings suggest that evaluation of these markers during initial transrectal ultrasound biopsies may decrease and prevent unnecessary prostate rebiopsy.

참고문헌 (17)

  1. Yazici S, "Predictors of prostate cancer in ultrasound-guided transperineal saturation biopsy in Turkish men with multiple prior negative biopsies", Urologia, 83, pp.71~76 (2016)
  2. Mosquera JM, "Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States", Clin Cancer Res, 15, pp.4706~4711 (2009)
  3. Borboroglu PG, "Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies", J Urol, 163, pp.158~162 (2000)
  4. Sanguedolce F, "Typing the atypical : diagnostic issues and predictive markers in suspicious prostate lesions", Crit Rev Clin Lab Sci, 54, pp.309~325 (2017)
  5. Kitagawa Y, "Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screening", Prostate Int, 1, pp.65~68 (2013)
  6. Chaux A, "Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas", Am J Surg Pathol, 35, pp.1014~1020 (2011)
  7. Mosquera JM, "Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications", Clin Cancer Res, 14, pp.3380~3385 (2008)
  8. Dell’Atti L, "The role of the serum testosterone levels as a predictor of prostate cancer in patients with atypical small acinar proliferation at the first prostate biopsy", Asian J Androl, 20, pp.15~18 (2018)
  9. Ryu JH, "Predictive factors of prostate cancer at repeat biopsy in patients with an initial diagnosis of atypical small acinar proliferation of the prostate", Korean J Urol, 51, pp.752~756 (2010)
  10. Kato T, "Analysis of repeated 24-core saturation prostate biopsy : inverse association between asymptomatic histological inflammation and prostate cancer detection", Oncol Lett, 12, pp.1132~1138 (2016)
  11. Varma M, "Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens : a study of 250 consecutive cases in a routine surgical pathology practice", Arch Pathol Lab Med, 126, pp.554~561 (2002)
  12. Bostwick DG, "Atypical small acinar proliferation in the prostate : clinical significance in 2006", Arch Pathol Lab Med, 130, pp.952~957 (2006)
  13. Montironi R, "Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies(also referred to as"atypical small acinar proliferation suspicious for but not diagnostic of malignancy")", Eur Urol, 50, pp.666~674 (2006)
  14. Magi-Galluzzi C, "Prostate cancer : diagnostic criteria and role of immunohistochemistry", Mod Pathol, 31(S1), pp.S12~S21 (2018)
  15. Liu H, "Immunohistochemical evaluation of ERG expression in various benign and malignant tissues", Ann Clin Lab Sci, 43, pp.3~9 (2013)
  16. Shah RB, "The diagnostic use of ERG in resolving an"atypical glands suspicious for cancer"diagnosis in prostate biopsies beyond that provided by basal cell and alpha-methylacyl-CoA-racemase markers", Hum Pathol, 44, pp.786~794 (2013)
  17. Mehra R, "Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma : molecular evidence for an independent group of diseases", Cancer Res, 67, pp.7991~7995 (2007)

관련 논문AI추천

ERG Immunohistochemistry and Clinicopathologic Characteristics in Korean Prostate Adenocarcinoma Patients이철, 문경철, 박정환, 서자희대한병리학회 · Journal of Pathology and Translational Medicine2012 · 제46권 제5호Intraductal Carcinoma of Prostate: A Comprehensive and Concise Review노재윤, 박용욱, Jordan A. Roberts, Ming Zhou대한병리학회 · Journal of Pathology and Translational Medicine2013 · 제47권 제4호Intraductal Carcinoma of Prostate: A Comprehensive and Concise Review노재윤, 박용욱, Jordan A. Roberts, Ming Zhou대한병리학회 · Journal of Pathology and Translational Medicine2013 · 제47권 제5호Intraductal Carcinoma of the Prostate Gland: Recent AdvancesJae Y. Ro, Mukul K. Divatia연세대학교의과대학 · Yonsei Medical Journal2016 · 제57권 제5호AMACR is a highly sensitive and specific immunohistochemical marker for diagnosing prostate cancer on biopsy: a systematic review and meta-analysisArchie Fontana Iskandar, Fransiskus Xaverius Rinaldi, Johannes Cansius Prihadi, Nicolas Daniel Widjanarko, Stevan Kristian Lionardi, Steven Alvianto대한병리학회 · Journal of Pathology and Translational Medicine2025 · 제59권 제4호Diverse Immunoprofile of Ductal Adenocarcinoma of the Prostate with an Emphasis on the Prognostic Factors고현정, 박자민, 정세운, 정휘정, 조영미, 한민규, 황희상, Anuja Kashikar Kekatpure대한병리학회 · Journal of Pathology and Translational Medicine2017 · 제51권 제5호

이 간행물의 다른 논문 (4건)